Carmell (NASDAQ:CTCX) Trading Down 8.5% – What’s Next?

Shares of Carmell Co. (NASDAQ:CTCX) were down 8.5% during mid-day trading on Friday . The stock traded as low as $0.19 and last traded at $0.19. Approximately 385,686 shares were traded during trading, a decline of 87% from the average daily volume of 3,037,237 shares. The stock had previously closed at $0.21.

Carmell Stock Performance

The firm has a 50-day moving average price of $0.32 and a 200-day moving average price of $0.34.

Hedge Funds Weigh In On Carmell

A hedge fund recently bought a new stake in Carmell stock. Antara Capital LP purchased a new stake in shares of Carmell Co. (NASDAQ:CTCX) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 100,000 shares of the company’s stock, valued at approximately $28,000. Carmell accounts for about 0.0% of Antara Capital LP’s investment portfolio, making the stock its 10th biggest position. Antara Capital LP owned 0.48% of Carmell as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.